DiNuzzo Private Wealth
DGX icon

DiNuzzo Private Wealth’s Quest Diagnostics DGX Stock Holding History

DiNuzzo Private Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.43K Hold
19
– – ﹤0.01% 431
2026
Q2 		$4.03K Hold
19
– – ﹤0.01% 457
2026
Q1 		$3.72K Hold
19
– – ﹤0.01% 454
2025
Q4 		$3.3K Hold
19
– – ﹤0.01% 477
2025
Q3 		$3.45K Sell
19
-1
-5% -$177 ﹤0.01% 461
2025
Q2 		$3.59K Buy
20
+1
+5% +$174 ﹤0.01% 442
2025
Q1 		$3.22K Buy
19
+1
+6% +$164 ﹤0.01% 447
2024
Q4 		$2.72K Hold
18
– – ﹤0.01% 495
2024
Q3 		$2.8K Buy
18
+2
+13% +$299 ﹤0.01% 498
2024
Q2 		$2.19K Buy
16
+2
+14% +$274 ﹤0.01% 492
2024
Q1 		$1.86K Sell
14
-1
-7% -$130 ﹤0.01% 496
2023
Q4 		$2.07K Buy
+15
New +$1.97K ﹤0.01% 422

Other funds holding DGX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Conning Inc
Conning Inc Hartford, Connecticut $3.25B AUM 18.91% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Moran Wealth Management
Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return
Boston Common Asset Management
Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

DiNuzzo Private Wealth's DGX Position: Q3 2026 in Review

DiNuzzo Private Wealth held its Quest Diagnostics (DGX) position steady in Q3 2026 at 19 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

DiNuzzo Private Wealth first reported a position in DGX in Q4 2023 and has held it in 12 quarters since. 368 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • DiNuzzo Private Wealth held 19 shares of Quest Diagnostics worth $4.43K as of Q3 2026.
  • DiNuzzo Private Wealth left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #431 holding.
  • DiNuzzo Private Wealth first reported a position in Quest Diagnostics in Q4 2023 and has held it in 12 quarters since.
  • 368 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.